Table 5.
Prevalence of MSD by lower body region.
| Reported MSD (% Students) | ||||
|---|---|---|---|---|
| Cohort | BOH1 | BOH3 | DDS1 | DDS4 |
| Lower Back | ||||
| Any symptoms | 33.3 | 62.5 | 44.7 | 64 |
| Persisted > 2 Days | 66.7 | 50 | 50 | 62.5 |
| Affected daily life | 66.7 | 30 | 29.4 | 25 |
| Needed treatment | 33.3 | 20 | 5.9 | 18.8 |
| Hips/Thighs | ||||
| Any symptoms | 0 | 18.8 | 6.6 | 3.8 |
| Persisted > 2 Days | 0 | 100 | 60 | 0 |
| Affected daily life | 0 | 66.7 | 60 | 0 |
| Needed treatment | 0 | 33.3 | 40 | 0 |
| Knees | ||||
| Any symptoms | 11.1 | 6.25 | 14.5 | 7.7 |
| Persisted > 2 Days | 50 | 100 | 63.6 | 100 |
| Affected daily life | 50 | 100 | 45.5 | 0 |
| Needed treatment | 50 | 100 | 18.2 | 0 |
| Calves/Lower Leg | ||||
| Any symptoms | 5.6 | 0 | 3.9 | 11.5 |
| Persisted > 2 Days | 0 | 0 | 33.3 | 33.3 |
| Affected daily life | 0 | 0 | 33.3 | 0 |
| Needed treatment | 0 | 0 | 0 | 0 |
| Ankles/Feet | ||||
| Any symptoms | 5.6 | 5.3 | 6.25 | 15.4 |
| Persisted > 2 Days | 100 | 75 | 100 | 100 |
| Affected daily life | 100 | 25 | 0 | 25 |
| Needed treatment | 0 | 0 | 0 | 25 |